SynthesisFrontiers in immunology2023

Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis.

Shibo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.